Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.070
-0.080 (-2.54%)
At close: May 22, 2026, 4:00 PM EDT
3.110
+0.040 (1.30%)
After-hours: May 22, 2026, 7:01 PM EDT
Sana Biotechnology Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Sana Biotechnology stock has a consensus rating of "Strong Buy" and an average price target of $8.57. The average 1-year stock price forecast is 179.15% higher than the current stock price, while the lowest is $7.00 (+128.01%) and the highest is $12 (+290.88%).
Price Target: $8.57 (+179.15%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 14, 2026.
Analyst Ratings
The average analyst rating for Sana Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +128.01% | Apr 14, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +128.01% | Mar 4, 2026 |
| Wedbush | Wedbush | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +95.44% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +193.16% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +160.59% | Oct 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.65
from -0.96
EPS Next Year
-0.65
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.59 | -0.59 | ||||
| Avg | -0.65 | -0.65 | ||||
| Low | -0.75 | -0.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.